文献速递脊柱关节炎

轴性脊柱关节炎从症状发作到诊断的衔接:分层筛查研究

Bridging the Gap Between Symptom Onset and Diagnosis in Axial Spondyloarthritis.
PubMed 文献 · Arthritis Care Res (Hoboken) · 2022-04-09

该前瞻性研究纳入405例初级保健腰痛患者,采用分层筛查流程:初级标准化临床筛查后,对腰痛>3个月且症状发作年龄<50岁者转诊至风湿科培训的物理治疗师进行二级筛查,并按炎症特征分为轴性SpA低、中、高风险或无风险。二级筛查灵敏度68%、特异度90%、阳性预测值80%、阴性预测值84%;最终15.6%诊断为轴性SpA,非放射学轴性SpA中位腰痛病程2年,强直性脊柱炎7年。

要点

  • 分层筛查中二级筛查灵敏度68%、特异度90%、阳性预测值80%、阴性预测值84%。
  • 初级至二级筛查中位等待时间15天,最终15.6%患者诊断为轴性SpA。
  • 非放射学轴性SpA中位腰痛病程2年,强直性脊柱炎7年。

核心结论

  • 分层跨专业筛查流程可促进持续性腰痛患者中轴性SpA的快速诊断,且具有较高精准度和准确性。

研究设计与样本

  • 前瞻性研究,405例在初级保健腰痛门诊就诊的成人接受初级标准化临床筛查。
  • 腰痛>3个月且症状发作年龄<50岁者转诊至接受高级风湿科培训的物理治疗师进行二级筛查。
  • 二级筛查将具有炎症特征的患者分为轴性SpA低、中、高风险或无风险,以轴性SpA专家风湿科医生的评估为参照标准。

主要发现

  • 研究队列平均年龄36.9±9.9岁,女性占55%,HLA-B27阳性率14.4%。
  • 初级筛查至二级筛查的中位等待时间为15天。
  • 风湿科医生评估无风险或低风险占64.9%,中风险或高风险占35.1%。
  • 二级筛查灵敏度68%、特异度90%、阳性预测值80%、阴性预测值84%。
  • 最终15.6%患者诊断为轴性SpA;非放射学轴性SpA中位腰痛病程2年,强直性脊柱炎7年。

关键数值与推荐

  • 初级筛查纳入标准:腰痛>3个月且症状发作年龄<50岁。
  • 二级筛查风险分层:低、中、高风险或无风险,以风湿科专家评估为参照。
  • 二级筛查灵敏度68%、特异度90%、阳性预测值80%、阴性预测值84%。

临床怎么用

  • 在初级保健中可对持续性腰痛且症状发作年龄<50岁者采用分层筛查流程快速转诊。
  • 二级筛查由接受风湿科培训的物理治疗师进行风险分层,有助于提高诊断精准度。
  • 该流程可缩短轴性SpA从症状发作到诊断的时间,尤其对非放射学轴性SpA。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate a stratified screening process for the early identification of axial spondyloarthritis (SpA) with consideration of the following: 1) wait times from primary care to rheumatology screen, 2) incremental precision and accuracy from primary care to rheumatology screening, and 3) diagnostic delay. METHODS: Adults with low back pain attending primary care at low back pain clinics prospectively underwent a primary standardized clinical screening. Patients with low back pain of >3 months who experienced symptom onset at age <50 years were referred for a comprehensive secondary screening by a physical therapist with advanced rheumatology training. At secondary screening, patients with features of inflammation were classified as being at a low, medium, or high risk for axial SpA versus no risk for axial SpA. Precision and accuracy of this screening strata were measured against a rheumatologist with expertise in axial SpA. RESULTS: Overall, 405 patients underwent primary and secondary screening in the present study. The study cohort had a mean ± SD age of 36.9 ± 9.9 years, and 55% were women. HLA-B27 was present in 14.4% of patients. Median wait time from primary screening to secondary screening was 15 days. Axial SpA risk assignment by rheumatologist was 64.9% for no risk or low risk for axial SpA and 35.1% for medium risk or high risk for axial SpA. The best combination of sensitivity (68%), specificity (90%), positive predictive values (80%), and negative predictive values (84%) was evident in the secondary screening. In this cohort, 15.6% of patients received a final diagnosis of axial SpA. Median low back pain duration from symptom onset to diagnosis was 2 years for nonradiographic axial SpA and 7 years for ankylosing spondylitis. CONCLUSION: A stratified interprofessional screening process can facilitate rapid diagnosis of persistent low back pain with high precision and accuracy in patients who have axial SpA.

来源:Arthritis Care Res (Hoboken),查看原文。版权归原作者所有。

引用

  1. Passalent L, Sundararajan K, Perruccio AV, et al. Bridging the Gap Between Symptom Onset and Diagnosis in Axial Spondyloarthritis. Arthritis Care Res (Hoboken). 2022. PMID: 34268914. doi:10.1002/acr.24751

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。